Concepedia

Author

Shuya Takahashi

Taisho Pharmaceutical (Japan)

Also Known As

Shuya Takahashi

12

Publications

126

Citations

5

H-Index

20

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)Nissan Chemical Corporation (Japan)
ST

About

Shuya Takahashi is an author at Taisho Pharmaceutical (Japan) specializing in medicine, fibrosis, and molecular physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

50

2

Health Sciences

1

1

16

3

Public Health

1

1

34

4

Applied Physiology

1

1

16

5

Cell Biology

1

1

34

Shuya Takahashi

×

4

Publications

115

Citations

4

H-Index

YearCitations

Cyclooxygenase inhibitors augment the production of pro‐matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes

Akira Ito, Takashi Nose, Shuya Takahashi,

FEBS Letters

1995

55

Involvement of protein kinase C in the interleukin 1α-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts

Shuya Takahashi, Takashi Sato, Akira Itô,

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

1993

34

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model

Norihisa Ishiwata, Kazuo Noguchi, Masafumi Kawanishi,

Life Sciences

2007

16

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects

Miyuki Hori, Takehisa Iwama, Yumiko Asakura,

European Journal of Pharmacology

2009

10

Page 1